Chemistry and Industry - FDA approves Crestor for AZ
Saturday, January 10th, 2009 AstraZeneca’s second-generation cholesterol drug, Crestor, has finally been approved by the US Food and Drug Administration (FDA).
The drug, which is seen as a key product for the company, has been approved at all doses, and without the kidney testing requirements that many were expecting for higher doses.
The drug has faced delays and safety conce…
